A detailed history of Graham Capital Management, L.P. transactions in Novavax Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 55,564 shares of NVAX stock, worth $470,627. This represents 0.02% of its overall portfolio holdings.

Number of Shares
55,564
Previous 78,939 29.61%
Holding current value
$470,627
Previous $999,000 29.83%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $250,346 - $399,946
-23,375 Reduced 29.61%
55,564 $701,000
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $307,072 - $1.66 Million
78,939 New
78,939 $999,000
Q1 2021

May 17, 2021

SELL
$112.98 - $319.93 $4.24 Million - $12 Million
-37,562 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.74 - $139.5 $2.96 Million - $5.24 Million
37,562 New
37,562 $4.19 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.